Immunity derived from vaccines and toxoids is described as having what characteristic duration?

Correct answer: Prolonged (years)

Explanation

This question assesses the understanding of the long-term nature of immunity conferred by active immunization through vaccines and toxoids.

Other questions

Question 1

What type of immunization do immune globulins provide, and what is the typical duration of this immunity?

Question 2

According to the 'General Action and Information' section, what is the maximum duration of the short-lived immunity provided by immune globulins?

Question 3

How do vaccines and toxoids provide immunization?

Question 4

What is the primary contraindication for the administration of vaccines and immunizing agents?

Question 5

The 'Contraindications' section mentions that some vaccine products may contain which specific components that can cause hypersensitivity reactions?

Question 6

What potential interaction is noted for patients receiving concurrent antineoplastic, immunosuppressive, or radiation therapy with vaccines or toxoids?

Question 7

What is a key assessment the nurse should perform before administering any immunizing agent?

Question 8

According to the patient teaching guidelines, at what fever temperature, in Fahrenheit, should a patient or parent notify a health care professional after an immunization?

Question 9

Which of the following is listed as a reportable side effect of immunization in the 'Patient/Family Teaching' section?

Question 10

The 'Implementation' section notes that which combination of vaccines may be given concurrently?

Question 11

What is the key difference in the source of antibodies between passive and active immunization as described in the text?

Question 12

Under what condition should a precaution be taken for IM injections of vaccines?

Question 13

What is the desired outcome of immunization with vaccines and toxoids?

Question 14

According to the patient teaching guidelines, at what fever temperature, in Celsius, should a health care professional be notified?

Question 16

Which of the following symptoms, if developed after an immunization, requires notification of a health care professional?

Question 17

What type of antigenic material is found in vaccines and toxoids to stimulate an immune response?

Question 18

What is the key nursing instruction regarding patient records after immunization?

Question 19

The administration of an immunizing agent is contraindicated in a patient with a known hypersensitivity to which of the following additives?

Question 20

A patient who is receiving radiation therapy is scheduled for a vaccination. Based on the 'Interactions' section, what should the nurse anticipate?

Question 21

Which of the following describes passive immunization as detailed in the text?

Question 22

What is the primary concern when administering an IM vaccine to a patient with severe bleeding problems?

Question 23

Which is an example of a reportable side effect following immunization that a patient or parent should be educated about?

Question 24

How does the text characterize the onset and duration of immunity from active immunization with a vaccine?

Question 25

A patient has a known severe allergy to egg protein. Based on the provided text, what is the implication for vaccination?

Question 26

What does the text say about the concurrent administration of diphtheria toxoid, tetanus toxoid, and pertussis vaccine?

Question 27

The text recommends that a parent/patient should notify a health care professional if which of these skin-related symptoms occur after immunization?

Question 28

What is the result of active immunization?

Question 29

Which statement accurately reflects the information on interactions between vaccines and immunosuppressive therapy?

Question 30

Besides convulsions and high fever, which other symptom is listed as a reason to notify a health care professional after an immunization?

Question 31

Which agent provides passive immunization?

Question 32

The text lists thimerosal as a potential additive in some immunizing products that can be a cause for what?

Question 33

What is the primary role of the antigenic material within a vaccine or toxoid?

Question 34

According to the 'Implementation' section, what is an important consideration when administering immunizations?

Question 35

The text specifies that immunity from immune globulins is rapid. How does this compare to the immunity from vaccines and toxoids?

Question 36

What is a potential nursing diagnosis related to the administration of vaccines and immunizing agents?

Question 37

Which combination of vaccines is mentioned in the 'Implementation' section as being able to be given concurrently?

Question 38

What is the primary difference in general use between immune globulins and vaccines?

Question 39

A patient with a history of hypersensitivity should be assessed carefully before receiving a vaccine. What specific information is most important to gather?

Question 40

What key piece of advice should be given to patients/parents regarding subsequent immunizations?

Question 41

What is the primary risk of administering a vaccine to a patient with a known allergy to thimerosal?

Question 42

How does the text describe the immunity provided by toxoids?

Question 43

What is a key instruction from the 'Implementation' section regarding trivalent oral polio virus vaccine?

Question 44

Which of these is NOT listed as a reportable side effect after an immunization?

Question 45

The immunity provided by immune globulins is described as short-lived, with a duration of up to how many months?

Question 46

What does the text indicate about giving the measles, mumps, and rubella (MMR) vaccine concurrently with other vaccines?

Question 47

If a patient experiences convulsions after an immunization, what should the patient or parent do?

Question 48

According to the 'General Action and Information' section, active immunization produces what kind of immunity?

Question 49

A key point in patient and family teaching is to emphasize the importance of keeping a record of what?

Question 50

What is the source of immunity in passive immunization?